M
MedChart
MedChart is a release of information platform that makes transfer of medical records easy and secure on the cloud
About MedChart
MedChart was founded in 2015 by James Bateman and Derrick Chow, who met as PhD students at the University of Toronto. Bateman's inspiration for the company came from a personal experience in 2013 with the burdensome process of accessing his late father-in-law's medical records, which were scattered across multiple hospitals, homecare agencies, and physicians. This firsthand frustration with the fractured health information system, an experience shared by his co-founder, fueled their mission. Bateman's own journey is unconventional, transitioning from a nine-year career as a licensed carpenter and business owner to studying quantum physics at the University of Toronto, where he earned multiple degrees, including a PhD.
The company operates a cloud-based platform that facilitates secure, patient-authorized access to digital health information for businesses beyond direct patient care. Its primary clients include law firms, insurance providers, and life sciences researchers who rely on medical records for tasks such as insurance underwriting and legal claims. MedChart's business model addresses the slow, paper-based process of medical record retrieval by offering a digitized, automated solution. The platform manages consent capture, identity verification, and compliance with privacy standards like HIPAA and PIPEDA, aggregating health records, medical imaging, and other data into a single digital record controlled by the patient.
MedChart's service provides a HIPAA-compliant, secure method for the release of medical information. It leverages artificial intelligence and machine learning to offer analytics and insights from the aggregated data, helping clients find critical information within large volumes of records. This is particularly valuable for law firms in personal injury, medical malpractice, and class-action cases. The platform features include a patient portal, document management, secure messaging, and an API that allows other businesses to integrate Medchart's data access capabilities into their own applications. Since its inception, the company has secured significant funding, including a combined $17 million in Seed and Series A rounds in April 2021, with investors like Crosslink Capital, Golden Ventures, and the rapper Nas.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2021 | $17M | $68M | Vast Ventures · IGan Partners · Union Ventures · Stanford Law School | ↗ |
| SEED✓Equity / VC | Apr 2018 | — | — | Undisclosed | — |
Growth signals
Latest recorded traffic for MedChart is 3.5K monthly website visits, down 36.4% over the last three months. MedChart's team grew 4.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Vast Ventures
IGan Partners- UVUnion Ventures
Stanford Law School
Crosslink Capital
Nasir Nas Jones
Other known investors2 additional known investors
University of Toronto
Golden Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedChart on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedChart’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







